Mylonakis E - Search Results

1

An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs.

Kim W, Hendricks GL, Lee K, Mylonakis E. Kim W, et al. Among authors: mylonakis e. Expert Opin Drug Discov. 2017 Jun;12(6):625-633. doi: 10.1080/17460441.2017.1319358. Epub 2017 Apr 21. Expert Opin Drug Discov. 2017. PMID: 28402221 Review.

2

Antifungal drug discovery through the study of invertebrate model hosts.

Pukkila-Worley R, Holson E, Wagner F, Mylonakis E. Pukkila-Worley R, et al. Among authors: mylonakis e. Curr Med Chem. 2009;16(13):1588-95. doi: 10.2174/092986709788186237. Curr Med Chem. 2009. PMID: 19442135 Free PMC article. Review.

3

Caenorhabditis elegans-based model systems for antifungal drug discovery.

Anastassopoulou CG, Fuchs BB, Mylonakis E. Anastassopoulou CG, et al. Among authors: mylonakis e. Curr Pharm Des. 2011;17(13):1225-33. doi: 10.2174/138161211795703753. Curr Pharm Des. 2011. PMID: 21470110 Free PMC article. Review.

4

Using C. elegans for antimicrobial drug discovery.

Desalermos A, Muhammed M, Glavis-Bloom J, Mylonakis E. Desalermos A, et al. Among authors: mylonakis e. Expert Opin Drug Discov. 2011 Jun 1;6(6):645-652. doi: 10.1517/17460441.2011.573781. Expert Opin Drug Discov. 2011. PMID: 21686092 Free PMC article.

5

C. elegans for anti-infective discovery.

Arvanitis M, Glavis-Bloom J, Mylonakis E. Arvanitis M, et al. Among authors: mylonakis e. Curr Opin Pharmacol. 2013 Oct;13(5):769-74. doi: 10.1016/j.coph.2013.08.002. Epub 2013 Aug 29. Curr Opin Pharmacol. 2013. PMID: 23993686 Review.

6

Apoptosis in C. elegans: lessons for cancer and immunity.

Arvanitis M, Li DD, Lee K, Mylonakis E. Arvanitis M, et al. Among authors: mylonakis e. Front Cell Infect Microbiol. 2013 Oct 18;3:67. doi: 10.3389/fcimb.2013.00067. eCollection 2013. Front Cell Infect Microbiol. 2013. PMID: 24151577 Free PMC article. Review. No abstract available.

7

Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus.

Rajamuthiah R, Fuchs BB, Jayamani E, Kim Y, Larkins-Ford J, Conery A, Ausubel FM, Mylonakis E. Rajamuthiah R, et al. Among authors: mylonakis e. PLoS One. 2014 Feb 19;9(2):e89189. doi: 10.1371/journal.pone.0089189. eCollection 2014. PLoS One. 2014. PMID: 24586584 Free PMC article.

8

Insect-derived cecropins display activity against Acinetobacter baumannii in a whole-animal high-throughput Caenorhabditis elegans model.

Jayamani E, Rajamuthiah R, Larkins-Ford J, Fuchs BB, Conery AL, Vilcinskas A, Ausubel FM, Mylonakis E. Jayamani E, et al. Among authors: mylonakis e. Antimicrob Agents Chemother. 2015 Mar;59(3):1728-37. doi: 10.1128/AAC.04198-14. Epub 2015 Jan 12. Antimicrob Agents Chemother. 2015. PMID: 25583713 Free PMC article.

9

Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus.

Rajamuthiah R, Fuchs BB, Conery AL, Kim W, Jayamani E, Kwon B, Ausubel FM, Mylonakis E. Rajamuthiah R, et al. Among authors: mylonakis e. PLoS One. 2015 Apr 21;10(4):e0124595. doi: 10.1371/journal.pone.0124595. eCollection 2015. PLoS One. 2015. PMID: 25897961 Free PMC article.

10

Identification of an Antimicrobial Agent Effective against Methicillin-Resistant Staphylococcus aureus Persisters Using a Fluorescence-Based Screening Strategy.

Kim W, Conery AL, Rajamuthiah R, Fuchs BB, Ausubel FM, Mylonakis E. Kim W, et al. Among authors: mylonakis e. PLoS One. 2015 Jun 3;10(6):e0127640. doi: 10.1371/journal.pone.0127640. eCollection 2015. PLoS One. 2015. PMID: 26039584 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters